IGFBP5 mediates high glucose-induced cardiac fibroblast activation.

This study examined whether IGF-binding protein 5 (IGFBP5) is involved in the high glucose-induced deteriorating effects in cardiac cells. Cardiac fibroblasts and cardiomyocytes were isolated from the hearts of 1- to 3-day-old Sprague Dawley rats. Treatment of fibroblasts with 25 mM glucose increased the number of cells and the mRNA levels of collagen III, matrix metalloproteinase 2 (MMP2), and MMP9. High glucose increased ERK1/2 activity, and the ERK1/2 inhibitor PD98059 suppressed high glucose-mediated fibroblast proliferation and increased collagen III mRNA levels. Whereas high glucose increased both mRNA and protein levels of IGFBP5 in fibroblasts, high glucose did not affect IGFBP5 protein levels in cardiomyocytes. The high glucose-induced increase in IGFBP5 protein levels was inhibited by PD98059 in fibroblasts. While recombinant IGFBP5 increased ERK phosphorylation, cell proliferation, and the mRNA levels of collagen III, MMP2, and MMP9 in fibroblasts, IGFBP5 increased c-Jun N-terminal kinase phosphorylation and induced apoptosis in cardiomyocytes. The knockdown of IGFBP5 inhibited high glucose-induced cell proliferation and collagen III mRNA levels in fibroblasts. Although high glucose increased IGF1 levels, IGF1 did not increase IGFBP5 levels in fibroblasts. The hearts of Otsuka Long-Evans Tokushima Fatty rats and the cardiac fibroblasts of streptozotocin-induced diabetic rats showed increased IGFBP5 expression. These results suggest that IGFBP5 mediates high glucose-induced profibrotic effects in cardiac fibroblasts.

[1]  W. Kuo,et al.  Diallyl trisufide (DATS) suppresses high glucose-induced cardiomyocyte apoptosis by inhibiting JNK/NFκB signaling via attenuating ROS generation. , 2013, International journal of cardiology.

[2]  Jing-kun Pan,et al.  High Glucose‐induced repression of RAR/RXR in cardiomyocytes is mediated through oxidative stress/JNK signaling , 2012, Journal of cellular physiology.

[3]  J. Qin,et al.  Insulin-like growth factor binding protein 5 suppresses tumor growth and metastasis of human osteosarcoma , 2011, Oncogene.

[4]  Quan Zhu,et al.  Inhibitory effects of two major isoflavonoids in Radix Astragali on high glucose-induced mesangial cells proliferation and AGEs-induced endothelial cells apoptosis. , 2011, Planta medica.

[5]  Liu Wei.  Immunological aspect of cardiac remodeling: T lymphocyte subsets in inflammation-mediated cardiac fibrosis. , 2011, Experimental and molecular pathology.

[6]  S. Zoungas,et al.  Cardiovascular outcomes in type 2 diabetes: the impact of preventative therapies , 2010, Annals of the New York Academy of Sciences.

[7]  In-kyu Lee,et al.  Adiponectin inhibits palmitate-induced apoptosis through suppression of reactive oxygen species in endothelial cells: involvement of cAMP/protein kinase A and AMP-activated protein kinase. , 2010, The Journal of endocrinology.

[8]  Scott M. Williams,et al.  Epigenetically altered wound healing in keloid fibroblasts. , 2010, The Journal of investigative dermatology.

[9]  Xulei Tang,et al.  Metformin reverses the deleterious effects of high glucose on osteoblast function. , 2010, Journal of diabetes and its complications.

[10]  L. Maile,et al.  Glucose Regulation of Thrombospondin and Its Role in the Modulation of Smooth Muscle Cell Proliferation , 2010, Experimental diabetes research.

[11]  E. Abel,et al.  Diabetic cardiomyopathy, causes and effects , 2010, Reviews in Endocrine and Metabolic Disorders.

[12]  P. Bosma,et al.  Insulin-like growth factor binding protein 5 enhances survival of LX2 human hepatic stellate cells , 2010, Fibrogenesis & tissue repair.

[13]  D. Morris,et al.  Reductions in laminin beta2 mRNA translation are responsible for impaired IGFBP-5-mediated mesangial cell migration in the presence of high glucose. , 2010, American journal of physiology. Renal physiology.

[14]  Stephanie L. K. Bowers,et al.  Cardiac Fibroblast: The Renaissance Cell , 2009, Circulation research.

[15]  Y. Yamaguchi,et al.  The pro-fibrotic factor IGFBP-5 induces lung fibroblast and mononuclear cell migration. , 2009, American journal of respiratory cell and molecular biology.

[16]  Rajesh Kumar,et al.  Intracellular Angiotensin II Production in Diabetic Rats Is Correlated With Cardiomyocyte Apoptosis, Oxidative Stress, and Cardiac Fibrosis , 2008, Diabetes.

[17]  C.-H. Wu,et al.  Insulin-like growth factor binding protein-5 enhances the migration and differentiation of gingival epithelial cells. , 2008, Journal of periodontal research.

[18]  P. Yin,et al.  IGFBP-5 regulates muscle cell differentiation by binding to IGF-II and switching on the IGF-II auto-regulation loop , 2008, The Journal of cell biology.

[19]  S. Mohr,et al.  Hyperglycemia-Induced Reactive Oxygen Species Toxicity to Endothelial Cells Is Dependent on Paracrine Mediators , 2008, Diabetes.

[20]  Rajesh Kumar,et al.  Activation of the intracellular renin-angiotensin system in cardiac fibroblasts by high glucose: role in extracellular matrix production. , 2008, American journal of physiology. Heart and circulatory physiology.

[21]  M. J. Kim,et al.  Induction of cellular senescence by insulin-like growth factor binding protein-5 through a p53-dependent mechanism. , 2007, Molecular biology of the cell.

[22]  Thomas K Borg,et al.  Determination of cell types and numbers during cardiac development in the neonatal and adult rat and mouse. , 2007, American journal of physiology. Heart and circulatory physiology.

[23]  W. Birchmeier,et al.  &bgr;-Catenin Downregulation Is Required for Adaptive Cardiac Remodeling , 2007, Circulation research.

[24]  Yun Zhang,et al.  High glucose promotes the production of collagen types I and III by cardiac fibroblasts through a pathway dependent on extracellular-signal-regulated kinase 1/2 , 2007, Molecular and Cellular Biochemistry.

[25]  C. Dominici,et al.  Bim-dependent apoptosis follows IGFBP-5 down-regulation in neuroblastoma cells. , 2006, Biochemical and biophysical research communications.

[26]  Soo-Hyun Park,et al.  TISSUE‐SPECIFIC REGULATION OF INSULIN‐LIKE GROWTH FACTORS AND INSULIN‐LIKE GROWTH FACTOR BINDING PROTEINS IN MALE DIABETIC RATS IN VIVO AND IN VITRO , 2006, Clinical and experimental pharmacology & physiology.

[27]  A. Choi,et al.  Insulin-like growth factor-binding protein-5 induces pulmonary fibrosis and triggers mononuclear cellular infiltration. , 2006, The American journal of pathology.

[28]  C. Abrass,et al.  Rat glomerular mesangial cells require laminin-9 to migrate in response to insulin-like growth factor binding protein-5. , 2006, American journal of physiology. Cell physiology.

[29]  D. Jukic,et al.  Insulin-like growth factor binding protein 5 induces skin fibrosis: A novel murine model for dermal fibrosis. , 2006, Arthritis and rheumatism.

[30]  S. Mohan,et al.  Ras‐Association Domain Family 1 Protein, RASSF1C, Is an IGFBP‐5 Binding Partner and a Potential Regulator of Osteoblast Cell Proliferation , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[31]  R. Baxter,et al.  Enhancement of tumor necrosis factor-alpha-induced growth inhibition by insulin-like growth factor-binding protein-5 (IGFBP-5), but not IGFBP-3 in human breast cancer cells. , 2005, Endocrinology.

[32]  A. Hoeflich,et al.  Insulin-like growth factor (IGF)-I stimulates cell proliferation and induces IGF binding protein (IGFBP)-3 and IGFBP-5 gene expression in cultured growth plate chondrocytes via distinct signaling pathways. , 2005, Endocrinology.

[33]  J. Pilewski,et al.  Insulin-like growth factor binding proteins 3 and 5 are overexpressed in idiopathic pulmonary fibrosis and contribute to extracellular matrix deposition. , 2005, The American journal of pathology.

[34]  G. Raschellà,et al.  Insulin‐like Growth Factor Binding Protein 5: Contribution to Growth and Differentiation of Neuroblastoma Cells , 2004, Annals of the New York Academy of Sciences.

[35]  T. Tokudome,et al.  Direct effects of high glucose and insulin on protein synthesis in cultured cardiac myocytes and DNA and collagen synthesis in cardiac fibroblasts. , 2004, Metabolism: clinical and experimental.

[36]  K. Bitar,et al.  IGF-I increases IGFBP-5 and collagen alpha1(I) mRNAs by the MAPK pathway in rat intestinal smooth muscle cells. , 2004, American journal of physiology. Gastrointestinal and liver physiology.

[37]  C. Holding,et al.  Partitioning of IGFBP-5 actions in myogenesis: IGF-independent anti-apoptotic function , 2004, Journal of Cell Science.

[38]  S. Mohan,et al.  IGF-binding proteins are multifunctional and act via IGF-dependent and -independent mechanisms. , 2002, The Journal of endocrinology.

[39]  J. Beattie,et al.  Insulin-like growth factor binding protein-5 (IGFBP-5) induces premature cell death in the mammary glands of transgenic mice. , 2002, Development.

[40]  S. Cook,et al.  Transcriptional Effects of Chronic Akt Activation in the Heart* , 2002, The Journal of Biological Chemistry.

[41]  J. Kuemmerle,et al.  Insulin-like Growth Factor-binding Protein-5 (IGFBP-5) Stimulates Growth and IGF-I Secretion in Human Intestinal Smooth Muscle by Ras-dependent Activation of p38 MAP Kinase and Erk1/2 Pathways* , 2002, The Journal of Biological Chemistry.

[42]  S. Mohan,et al.  Insulin-like Growth Factor-binding Protein 5 (IGFBP-5) Interacts with a Four and a Half LIM Protein 2 (FHL2)* , 2002, The Journal of Biological Chemistry.

[43]  A. Hoeflich,et al.  IGF-binding protein-5: flexible player in the IGF system and effector on its own. , 2002, The Journal of endocrinology.

[44]  K. Huse,et al.  Aldosterone and d-Glucose Stimulate the Proliferation of Human Cardiac Myofibroblasts In Vitro , 2002, Hypertension.

[45]  W. Lowe,et al.  Activation of members of the mitogen-activated protein kinase family by glucose in endothelial cells. , 2000, American journal of physiology. Endocrinology and metabolism.

[46]  V. Hwa,et al.  The insulin-like growth factor-binding protein (IGFBP) superfamily. , 1999, Endocrine reviews.

[47]  T. Wright,et al.  Identification of multiple, differentially expressed messenger RNAs in dermal fibroblasts from patients with systemic sclerosis. , 1999, Arthritis and rheumatism.

[48]  H. Abboud,et al.  Preferential expression of insulin-like growth factor binding proteins-1, -3, and -5 during early diabetic renal hypertrophy in rats. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[49]  R. Baxter,et al.  Insulin-like Growth Factor-binding Protein (IGFBP)-3 and IGFBP-5 Share a Common Nuclear Transport Pathway in T47D Human Breast Carcinoma Cells* , 1998, The Journal of Biological Chemistry.

[50]  S. Mohan,et al.  Studies on the Mechanisms by Which Insulin-like Growth Factor (IGF) Binding Protein-4 (IGFBP-4) and IGFBP-5 Modulate IGF Actions in Bone Cells (*) , 1995, The Journal of Biological Chemistry.

[51]  J. Schaper,et al.  Insulin-like growth factor II is an experimental stress inducible gene in a porcine model of brief coronary occlusions. , 1995, Cardiovascular research.

[52]  M. Shimizu,et al.  Collagen remodelling in myocardia of patients with diabetes. , 1993, Journal of clinical pathology.

[53]  Huixia Lu,et al.  The role of thrombospondin-1-mediated TGF-β1 on collagen type III synthesis induced by high glucose , 2010, Molecular and Cellular Biochemistry.